BreviTest co-founder discusses technology that reduces diagnostic times


Dr. Dev Chatterjee has developed an ultra–fast diagnostic device that can diagnose Ebola in the time it takes to brew coffee. Chatterjee, co-founder of BreviTest, takes a novel approach that re-imagines the immunoassay method as serial reactions in connected microfluidic chambers, which eliminates the traditional requirement of multiple washes to comprehensively remove residual reactants. BreviTest’s patent-pending technology has been reduced to practice with a prototype that successfully demonstrated completely automated ELISA reactions.

Want to stay on top of MDO content? Subscribe to our e-newsletter.

Speak Your Mind